

Product: Semaglutide
Description: CAS: 166108-71-0; Semaglutide manufacturer; Semaglutide intermediate; Diabetics
Category: Semaglutide
In-stock: In Stock
Payment Method: T/T, L/C
Shipping Method: Express, AIR
Product Information
CAS No. |
166108-71-0
|
End Use | Semaglutide |
M.F. | C21H23NO6 |
M.W. | 385.41 |
Assay | 98% |
Shelf Life | 2 Years |
Package | Vial Or LDPE+Aluminum Package |
Highlight | FARMASINO CAS: 166108-71-0 Semaglutide FARMASINO Semaglutide CAS: 166108-71-0 FARMASINO Fmoc-AEEA-OH Semaglutide |
Related Products
Additional Information
Application
- This compound is related intermediate for synthesis of the side chain of Semaglutide.
- Peptide Synthesis:Fmoc-AEEA-OH is a building block for the synthesis of peptides. It can be coupled with other amino acid derivatives to form peptide chains. The Fmoc group allows for selective deprotection of the amino group, which is necessary for the coupling reaction.
- Bioconjugation:The amino group of Fmoc-AEEA-OH can be used for bioconjugation reactions, attaching it to other molecules such as drugs, dyes, or targeting ligands. This allows for the creation of functionalized peptides with enhanced properties or for site-specific delivery of therapeutic agents.
- Drug Discovery and Therapeutics:Fmoc-AEEA-OH and its derivatives may have pharmaceutical properties that make them candidates for drug discovery. The aminoethylglycine (AEEA) moiety may confer specific biological activities that are therapeutically beneficial.
- Protein Engineering:In protein engineering, Fmoc-AEEA-OH can be used to introduce specific amino acid substitutions into proteins. This can be achieved by synthesizing peptides containing Fmoc-AEEA-OH and then ligating them into proteins using site-specific ligation methods.